Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Tomorrows the day
View:
Post by Legit62 on Nov 27, 2022 10:19am

Tomorrows the day

Yoly you will be very happy tomorrow when we get the news you have been waiting for, we will all be happy, and Yoly, your glass will be half full not half empty
Comment by Legit62 on Nov 27, 2022 10:20am
And you and Roger can Kiss and make up
Comment by Oilminerdeluxe on Nov 27, 2022 10:46am
Bound to be news sooner or later now. Would be nice to have an update on things. If they are good that is. I can imagine a bunch of capital is on the sidelines until the next data is here. A solid improvement in CR, PR and TR could bring tears of joy if that money is rushed into TLT. Well, one can hope anyway.
Comment by Yoly900 on Nov 27, 2022 11:47am
Save your money so much better opportunity than this pos. ROGER IS A SCAM SCUM. If you follow these smucks don't know what to tell you 0.45 and than drop hammer arjadymanscammmmmm! I'll be at agm next year try to take chrissy in my arms take her away from ROGER WHITE. PS he's got s small Pepe 
Comment by consultant99 on Nov 27, 2022 1:41pm
There will be an update when the company releases their quarterly results in the management notes  at the end of November.  My expectation is the company will make a PR when they submit their BTD and AA applications. That said if they don't I would expect something in the management notes regarding the 25th patient status and the application process for BTD and AA.
Comment by Yoly900 on Nov 27, 2022 1:44pm
I sold my shares july all I want for Christmas is Chrissy in my bed naked Gogo Gogo Ho Ho Ho Ho 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250